🇺🇸 FDA
Pipeline program

AKB-6548 tablet, reference formulation given in the fasted state

AKB-6548-CI-0013

Phase 1 small_molecule completed

Quick answer

AKB-6548 tablet, reference formulation given in the fasted state for Healthy is a Phase 1 program (small_molecule) at Akebia Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Akebia Therapeutics
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials